In fintech and healthcare, early-stage valuations are on different paths
Introduction In the evolving venture capital landscape of 2025, early‑stage valuations in fintech and healthcare display a striking valuation divergence. Fintech valuations have experienced a pullback after a pandemic boom, whereas healthcare—especially biotech and digital health—is enjoying sustained investor enthusiasm. This divergence is reshaping startup strategies and investment priorities in both sectors. 1. Macro Snapshot: […]